Copyright Reports & Markets. All rights reserved.

Covid-19 Impact on Animal Antibiotics and Antimicrobials Market, Global Research Reports 2020-2021

Request for Sample of this report
Buy now
  • 1.1 Research Scope
  • 1.2 Market Segmentation
  • 1.3 Research Objectives
  • 1.4 Research Methodology
    • 1.4.1 Research Process
    • 1.4.2 Data Triangulation
    • 1.4.3 Research Approach
    • 1.4.4 Base Year
  • 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
    • 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
    • 1.5.2 Covid-19 Impact: Commodity Prices Indices
    • 1.5.3 Covid-19 Impact: Global Major Government Policy
  • 1.6 The Covid-19 Impact on Animal Antibiotics and Antimicrobials Industry
  • 1.7 COVID-19 Impact: Animal Antibiotics and Antimicrobials Market Trends

    • 2 Global Animal Antibiotics and Antimicrobials Quarterly Market Size Analysis

    • 2.1 Animal Antibiotics and Antimicrobials Business Impact Assessment - COVID-19
      • 2.1.1 Global Animal Antibiotics and Antimicrobials Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
    • 2.2 Global Animal Antibiotics and Antimicrobials Quarterly Market Size 2020-2021
    • 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
      • 2.3.1 Drivers
      • 2.3.2 Restraints
      • 2.3.3 Opportunities
      • 2.3.4 Challenges

    3 Quarterly Competitive Assessment, 2020

    • 3.1 By Players, Global Animal Antibiotics and Antimicrobials Quarterly Market Size, 2019 VS 2020
    • 3.2 By Players, Animal Antibiotics and Antimicrobials Headquarters and Area Served
    • 3.3 Date of Key Players Enter into Animal Antibiotics and Antimicrobials Market
    • 3.4 Key Players Animal Antibiotics and Antimicrobials Product Offered
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Impact of Covid-19 on Animal Antibiotics and Antimicrobials Segments, By Type

    • 4.1 Introduction
      • 1.4.1 Etracyclines
      • 1.4.2 Penicillins
      • 1.4.3 Macrolides
      • 1.4.4 Aminoglycosides
      • 1.4.5 Sulfonamides
      • 1.4.6 Fluoroquinolones
      • 1.4.7 Lincosamides
      • 1.4.8 Cephalosporins
      • 1.4.9 Other
    • 4.2 By Type, Global Animal Antibiotics and Antimicrobials Market Size, 2019-2021

    5 Impact of Covid-19 on Animal Antibiotics and Antimicrobials Segments, By Application

    • 5.1 Overview
      • 5.5.1 Food-producing Animals
      • 5.5.2 Companion Animals
    • 5.2 By Application, Global Animal Antibiotics and Antimicrobials Market Size, 2019-2021
      • 5.2.1 By Application, Global Animal Antibiotics and Antimicrobials Market Size by Application, 2019-2021

    6 Geographic Analysis

    • 6.1 Introduction
    • 6.2 North America
      • 6.2.1 Macroeconomic Indicators of US
      • 6.2.2 US
      • 6.2.3 Canada
    • 6.3 Europe
      • 6.3.1 Macroeconomic Indicators of Europe
      • 6.3.2 Germany
      • 6.3.3 France
      • 6.3.4 UK
      • 6.3.5 Italy
    • 6.4 Asia-Pacific
      • 6.4.1 Macroeconomic Indicators of Asia-Pacific
      • 6.4.2 China
      • 6.4.3 Japan
      • 6.4.4 South Korea
      • 6.4.5 India
      • 6.4.6 ASEAN
    • 6.5 Rest of World
      • 6.5.1 Latin America
      • 6.5.2 Middle East and Africa

    7 Company Profiles

    • 7.1 Zoetis, Inc.
      • 7.1.1 Zoetis, Inc. Business Overview
      • 7.1.2 Zoetis, Inc. Animal Antibiotics and Antimicrobials Quarterly Revenue, 2020
      • 7.1.3 Zoetis, Inc. Animal Antibiotics and Antimicrobials Product Introduction
      • 7.1.4 Zoetis, Inc. Response to COVID-19 and Related Developments
    • 7.2 Merck & Co., Inc.
      • 7.2.1 Merck & Co., Inc. Business Overview
      • 7.2.2 Merck & Co., Inc. Animal Antibiotics and Antimicrobials Quarterly Revenue, 2020
      • 7.2.3 Merck & Co., Inc. Animal Antibiotics and Antimicrobials Product Introduction
      • 7.2.4 Merck & Co., Inc. Response to COVID-19 and Related Developments
    • 7.3 Eli Lilly and Company
      • 7.3.1 Eli Lilly and Company Business Overview
      • 7.3.2 Eli Lilly and Company Animal Antibiotics and Antimicrobials Quarterly Revenue, 2020
      • 7.3.3 Eli Lilly and Company Animal Antibiotics and Antimicrobials Product Introduction
      • 7.3.4 Eli Lilly and Company Response to COVID-19 and Related Developments
    • 7.4 Bayer AG
      • 7.4.1 Bayer AG Business Overview
      • 7.4.2 Bayer AG Animal Antibiotics and Antimicrobials Quarterly Revenue, 2020
      • 7.4.3 Bayer AG Animal Antibiotics and Antimicrobials Product Introduction
      • 7.4.4 Bayer AG Response to COVID-19 and Related Developments
    • 7.5 Virbac
      • 7.5.1 Virbac Business Overview
      • 7.5.2 Virbac Animal Antibiotics and Antimicrobials Quarterly Revenue, 2020
      • 7.5.3 Virbac Animal Antibiotics and Antimicrobials Product Introduction
      • 7.5.4 Virbac Response to COVID-19 and Related Developments
    • 7.6 Boehringer Ingelheim GmbH
      • 7.6.1 Boehringer Ingelheim GmbH Business Overview
      • 7.6.2 Boehringer Ingelheim GmbH Animal Antibiotics and Antimicrobials Quarterly Revenue, 2020
      • 7.6.3 Boehringer Ingelheim GmbH Animal Antibiotics and Antimicrobials Product Introduction
      • 7.6.4 Boehringer Ingelheim GmbH Response to COVID-19 and Related Developments
    • 7.7 Sanofi
      • 7.7.1 Sanofi Business Overview
      • 7.7.2 Sanofi Animal Antibiotics and Antimicrobials Quarterly Revenue, 2020
      • 7.7.3 Sanofi Animal Antibiotics and Antimicrobials Product Introduction
      • 7.7.4 Sanofi Response to COVID-19 and Related Developments
    • 7.8 Ceva Sante Animale
      • 7.8.1 Ceva Sante Animale Business Overview
      • 7.8.2 Ceva Sante Animale Animal Antibiotics and Antimicrobials Quarterly Revenue, 2020
      • 7.8.3 Ceva Sante Animale Animal Antibiotics and Antimicrobials Product Introduction
      • 7.8.4 Ceva Sante Animale Response to COVID-19 and Related Developments
    • 7.9 Vetoquinol S.A.
      • 7.9.1 Vetoquinol S.A. Business Overview
      • 7.9.2 Vetoquinol S.A. Animal Antibiotics and Antimicrobials Quarterly Revenue, 2020
      • 7.9.3 Vetoquinol S.A. Animal Antibiotics and Antimicrobials Product Introduction
      • 7.9.4 Vetoquinol S.A. Response to COVID-19 and Related Developments
    • 7.10 Dechra Pharmaceuticals PLC
      • 7.10.1 Dechra Pharmaceuticals PLC Business Overview
      • 7.10.2 Dechra Pharmaceuticals PLC Animal Antibiotics and Antimicrobials Quarterly Revenue, 2020
      • 7.10.3 Dechra Pharmaceuticals PLC Animal Antibiotics and Antimicrobials Product Introduction
      • 7.10.4 Dechra Pharmaceuticals PLC Response to COVID-19 and Related Developments

    8 Key Findings

      9 Appendix

      • 9.1 About US

      This report covers market size and forecasts of Animal Antibiotics and Antimicrobials, including the following market information:
      Global Animal Antibiotics and Antimicrobials Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
      Global Animal Antibiotics and Antimicrobials Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
      Global Animal Antibiotics and Antimicrobials Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
      Global Animal Antibiotics and Antimicrobials Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)

      Key market players
      Major competitors identified in this market include Zoetis, Inc., Merck & Co., Inc., Eli Lilly and Company, Bayer AG, Virbac, Boehringer Ingelheim GmbH, Sanofi, Ceva Sante Animale, Vetoquinol S.A., Dechra Pharmaceuticals PLC, etc.

      Based on the Region:
      Asia-Pacific (China, Japan, South Korea, India and ASEAN)
      North America (US and Canada)
      Europe (Germany, France, UK and Italy)
      Rest of World (Latin America, Middle East & Africa)

      Based on the Type:
      Etracyclines
      Penicillins
      Macrolides
      Aminoglycosides
      Sulfonamides
      Fluoroquinolones
      Lincosamides
      Cephalosporins
      Other

      Based on the Application:
      Food-producing Animals
      Companion Animals

      Buy now